$32.00

i 2.00 Hours

Course Overview

A diagnosis of cancer can be a life-changing, highly debilitating event severe enough to impact activities of daily living and quality of life. Strategic cancer principles and treatments are the foundation of appropriate medication use, adverse effect management, and curative outcomes. The goal of this continuing education program is to update healthcare professionals' knowledge regarding the role of the cell life cycle in drug selection and treatment, with minimal toxicity, for various cancer types.

About the Course Author

Diana Rangaves, PharmD, RPh, is a writer, editor for Doctorpedia.com, and award-winning teacher.Rangaves graduated with her Doctor of Pharmacy degree in 1983 from the University of California. Diana Rangaves, PharmD, RPh has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.

Get started now and your first course is free!


Become a member today and enjoy instant savings on all courses

Accreditation Information

Certificates provided by accrediting body (2 Match)

  • Accreditation Council for Pharmacy Education

    2.00HOURS


    In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


    Type Activity: Knowledge
    Target Audience Designation: P
    ACPE Universal Activity Number: JA4008266-0000-21-151-H01-P
  • Florida Board of Pharmacy

    2.00HOURS


    Florida Board of Pharmacy (CEBroker Provider #50-290)

    This module is approved for 2.0 contact hours.


Course Details
  • Course Code:

    REL-ACU-0-PHARM151
  • Hours:

    2.00
  • Type:

    Online Course
  • Release Date:

    2020-05-01
  • Expiration Date:

    2022-02-28
  • Learning Objectives:

    Describe the chemotherapy drug classifications and mechanisms of action pertaining to alkylating agents, antimetabolites, anthracyclines, antitumor cytotoxic antibiotics, mitotic inhibitors, plant vinca alkaloids and anti-microtubule/taxanes, targeted therapies, and miscellaneous antineoplastic agents in the treatment of cancer; Discuss the role the cancer cell life cycle plays in the selection of antineoplastic agents to strategically treat cancer; List the different adverse effects of and management techniques for anticancer drugs
  • Outline:

    Introduction
    About This Course
    Learning Objectives
    Content Page 1
    Cell Life Cycle
    Principles of Chemotherapy
    Content Page 2
    Anti-Cancer Drugs
    Alkylating Agents
    Antimetabolites
    Mitotic Inhibitors: Plant Alkaloids and Anti-microtubules/Taxanes
    Targeted Therapies
    Miscellaneous Antineoplastic Agents
    Content Page 3
    Cancer Drugs' Adverse Effects
    Clinical Vignette
    Conclusion
    Summary
    Glossary of Anti-Cancer Agents
    References
    Congratulations!
  • Target Audience:

    The target audience for this course is: Pharmacists; in the following settings: Acute Care Facility.
  • Course Delivery Method and Format:

    Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
    Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
    If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
    All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
    Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
    All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
    To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
  • Accommodations:

    If you require special accommodations to complete this module, please contact Relias Customer Support here.
  • Disclosures:

    Expert Reviewers, Instructors, and Staff Writers disclosures will be listed above after the individuals' biographical paragraph. All other members involved within the planning of this educational activity have declared no conflict of interest exists when planning and developing this course.